A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer

A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer

Saved in:

Bibliographic Details
Main Authors:	Ji‐Yong Sung, Jae‐Ho Cheong, Kihye Shin, Eui Tae Kim
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.70079
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fecal methylated syndecan-2 (SDC2) testing for early screening of colorectal cancerous and precancerous lesions: A real-world retrospective study in China
by: Boyu Qin, et al.
Published: (2025-01-01)

Overexpression of FERM Domain Containing Kindlin 2 (FERMT2) in Fibroblasts Correlates with EMT and Immunosuppression in Gastric Cancer
by: Sheng-yan Yin, et al.
Published: (2024-01-01)

Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer
by: Mikito Inokuchi, et al.
Published: (2015-01-01)

(t, n) threshold secret sharing scheme without SDC
by: ZHOU Fu-cai, et al.
Published: (2006-01-01)

Dual-positive gastric cancer: an extremely malignant subtype of gastric cancer with high serum alpha-fetoprotein and carcinoembryonic antigen concentrations
by: Weixun Xie, et al.
Published: (2025-01-01)

PDPN+ cancer‐associated fibroblasts enhance gastric cancer angiogenesis via AKT/NF‐κB activation and the CCL2‐ACKR1 axis
by: Zhenxiong Zhao, et al.
Published: (2025-01-01)

COX-2 Inhibitors and Gastric Cancer
by: Zhen Wang, et al.
Published: (2014-01-01)

Implication of fibroblast growth factor 7 in ovarian cancer metastases and patient survival
by: Laura F. Mortan, et al.
Published: (2025-01-01)

Novel treatment strategy targeting interleukin-6 induced by cancer associated fibroblasts for peritoneal metastasis of gastric cancer
by: Ema Mitsui, et al.
Published: (2025-01-01)

Concomitant Usage of H1‐Antihistamines and Immune Checkpoint Inhibitors on Cancer Patient Survival
by: Yin Leung, et al.
Published: (2025-01-01)

没有SDC的（t,n）门限秘密共享方案
by: 周福才, et al.
Published: (2006-01-01)

Identification of disulfidptosis-related subtypes in gastric cancer and GAMT is a key gene during disulfidptosis
by: Wenxue Wu, et al.
Published: (2025-01-01)

Evaluating survival outcomes and treatment recommendations in resectable gastric cancer
by: Saad Sabbagh, et al.
Published: (2025-01-01)

Regulated Shedding of Syndecan Ectodomains by Chemokines
by: Nathalie Charnaux, et al.
Published: (2006-01-01)

Subtype-specific prognostic impact of Bcl-2 in HER2-positive and HER2-negative breast cancer
by: Taeyeong Kim, et al.
Published: (2025-01-01)

Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy
by: Qiong Yang, et al.
Published: (2013-01-01)

Cancer-associated fibroblasts in carcinogenesis
by: Shufen Zhou, et al.
Published: (2025-01-01)

The Expression of Bcl-2 and BID in Gastric Cancer Cells
by: Mariusz Gryko, et al.
Published: (2014-01-01)

Syndecan-4 is More Sensitive in Detecting Hypertensive Left Ventricular Diastolic Dysfunction in 2K2C Rats
by: Wenyue Dai, et al.
Published: (2022-01-01)

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types
by: Vivek Subbiah, et al.
Published: (2025-02-01)

Syndecan-1 as a Regulator of Chemokine Function
by: Martin Götte, et al.
Published: (2003-01-01)

Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
by: Zhongsong Zhang, et al.
Published: (2025-01-01)

Chemotherapy for Metastatic Gastric Cancer
by: Sung Eun Kim, et al.
Published: (2025-01-01)

A Golgi apparatus‑related subtype and risk signature predicts prognosis and evaluates immunotherapy response in gastric cancer
by: Ruyue Chen, et al.
Published: (2025-01-01)

Incidence and Survival for Gastric and Esophageal Cancer Diagnosed in British Columbia, 1990 to 1999
by: Morteza Bashash, et al.
Published: (2008-01-01)

Mysterious Tasks of Tyrosines in Syndecan-1 Cytoplasmic Tail
by: Patricia Rousselle, et al.
Published: (2009-01-01)

Syndecan-1 as a Mediator of Bacteria-Enterocyte Interactions
by: Michelle Henry-Stanley, et al.
Published: (2006-01-01)

Molecular subtype of gastric cancer based on apoptosis-related genes reveals differential immune microenvironment and intratumoral microorganisms distribution
by: Xuan Yu, et al.
Published: (2025-01-01)

Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
by: Francesca De Felice, et al.
Published: (2015-01-01)

A Case of Long-Term Survival after Checkpoint Inhibitor Pneumonitis in a Patient with Squamous Cell Lung Cancer
by: Hironori Ashinuma, et al.
Published: (2019-01-01)

Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival
by: Bárbara Mora-Lagos, et al.
Published: (2025-01-01)

Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery
by: Yonghe Chen, et al.
Published: (2021-01-01)

Characterization of Somatostatin Receptor Subtype 2 Expression in Stably Transfected A-427 Human Cancer Cells
by: Jesse J. Parry, et al.
Published: (2007-01-01)

Comprehensive Complication Index Predicts Cancer-Specific Survival of Patients with Postoperative Complications after Curative Resection of Gastric Cancer
by: Ru-Hong Tu, et al.
Published: (2018-01-01)

Cancer-associated fibroblasts and their role in tumor progression
by: M. S. Ermakov, et al.
Published: (2022-03-01)

Desmoglein-2 was a novel cancer-associated fibroblasts-related biomarker for oral squamous cell carcinoma
by: Jin Liu, et al.
Published: (2025-01-01)

Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts through regulation of the HOXA6/ZBTB12 axis
by: Liu Haibo, et al.
Published: (2023-09-01)

New pathogen for gastric cancer: Streptococcus anginosus
by: Ruijie Zeng, et al.
Published: (2024-12-01)

Bilayer 3D co‐culture platform inducing the differentiation of normal fibroblasts into cancer‐associated fibroblast like cells: New in vitro source to obtain cancer‐associated fibroblasts
by: Yeon Ju Kim, et al.
Published: (2025-01-01)

Pan-cancer analysis of SOX2: Prognostic implications and potential as a therapeutic target in immune checkpoint modulation
by: Shoukai Yu, et al.
Published: (2025-02-01)